Opportunities in the U.S. Large Molecule Drug Substance CDMO Market

agregó una foto Health

2026-04-03 20:40:19 - Translate -

The U.S. Large Molecule Drug Substance CDMO Market is poised for significant expansion, supported by technological advancements, increasing biologics demand, and evolving pharmaceutical outsourcing strategies. With a projected CAGR of 7.5% through 2034, the market demonstrates strong growth potential across the biopharmaceutical sector. The market forecast for 2030 and beyond indicates...

0 Commentarios 0 Acciones 118 Views 0 Vista previa